In triple negative breast cancer, TEM8/ANTXR1, is marker of vasculogenic mimicry, and is associated with poor outcomes (Fernández-Cortés et al., 2019; Xu et al., 2021). Here, ANTXR1 is linked to triple-negative breast carcinoma.